A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation

Nature Medicine

Volumn 4, Issue 3, 1998, Pages 350-353

  Kostrikis, Leondios G ^a   Huang, Yaoxing ^a   Moore, John P ^a   Wolinsky, Steve M ^b   Zhang, Linqi ^a   Guo, Yong ^a   Deutsch, Lisa ^c   Phair, John ^b   Neumann, Avidan U ^c   Ho, David D ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c BAR ILAN UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR;

ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE; VIRUS CELL INTERACTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031915155     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0398-350     Document Type: Article

References (21)

1. Fauci, A.S. Host factors and the pathogenesis of HIV-induced disease. Nature 384, 529-534 (1996).
2. Moore, J.P., Trkola, A. & Dragic, T. Co-receptors for HIV-1 entry. Curr. Opin. Immunol. 9, 551-562 (1997).
3. Berger, E.A. HIV entry and tropism: the chemokine receptor connection. AIDS 11 (suppl A), S3-516 (1997).
4. Berger, E.A. et al. HIV-1 phenotype classified by co-receptor usage. Nature 391, 240 (1998).
5. Zhu, T. et al. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261, 1179-1181 (1993).
6. Richman, D.D. & Bozzette, S.A. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J. Inf. Dis. 169, 968-974 (1994).
7. Liu, R. et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367-378 (1996).
8. Samson, M. et al. Resistance to HIV-1 infection of Caucasian individuals bearing mutant alleles of the CKR5 chemokine receptor gene. Nature 382, 722-725 (1996).
9. Dean, M. et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion of the CKR5 structural allele. Science 273, 1856-1862 (1996).
10. Huang, Y. et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med. 2, 1240-1243 (1996).
11. Smith, M.W. et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 277, 959-965 (1997).
12. Michael, N.L et al. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. Nature Med. 3, 1160-1162 (1997).
13. Kostrikis, L.G., Tyagi, S., Mhlanga, M.M., Ho, D.D. & Kramer, F.R. Spectral genotyping of human alleles. Science (in the press).
14. Smith, M.W. et al. CCR2 chemokine receptor and AIDS progression. Nature Med. 3, 1052-1053 (1997).
15. Mummidi, S., Ahuja, S.S., McDaniel, B. & Ahuja, S.K. The human CC chemokine receptor 5 (CCR5) gene: Multiple transcripts with 5′-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons.). Biol. Chem. 272, 30662-30671 (1997).
16. Tyagi, S. & Kramer, F. Molecular beacons: probe that fluorescence upon hybridization. Nature Biotech. 14, 471-476 (1996).
17. Premack, B.A. & Schall, T.J. Chemokine receptors: gateways to inflammation and infection. Nature Med. 2, 1174-1178 (1996).
18. Paxton, W.A. et al. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nature Med. 2, 412-417 (1996).
19. Wu, L. et al. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J. Exp. Med. 185, 1681-1691 (1997).
20. Trkola, A. et al. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR5. Nature 384, 184-186 (1996).
21. Moore, J.P. Co-receptors: Implications for HIV pathogenesis and therapy. Science 276, 51-52 (1997).